Summary
The hepatic cytochrome P450 system participates in the oxidative metabolism of numerous endogenous and exogenous compounds. In total several hundred different P450s have been cloned, but it appears that in humans only about 5–10 isoforms account for the major part of drug metabolism. Some of these are polymorphically distributed in the population. Cytochrome P450 2D6 catalyzes the oxidation of over 25 clinically important drugs, eg neuroleptics, antidepressants and lipophilic β-blockers. Seven % of Caucasians and 1% of Orientals are defective in this enzyme and clearance of drugs metabolized by the enzyme may be substantially decreased in these individuals, with potentially increased risks for side effects caused by the drug treatment. Some individuals are ultrarapid metabolizers and do not achieve therapeutic drug levels at ordinary doses. The molecular genetic basis of these polymorphisms are presented. Methods for genotyping, which can be of predictive value for a more efficient drug therapy, are discussed. Ethanol-inducible cytochrome P450 2E1 (CYP2E1) oxidizes ethanol and acetaldehyde, in addition to over 80 toxicologically important xenobiotics. Furthermore, this isozyme produces reactive oxy radicals which are implicated in the aetiology of alcoholic liver disease. The gene is polymorphic and a mutation in a putative binding site for HNF1, described to affect gene expression, is more rare among subjects with lung cancer as compared to healthy controls. Further studies might give an answer as to whether any of the polymorphic CYP2E1 alleles is associated with the sensitivity to obtain alcoholic liver disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersson, T., Regârdh, C.G., Lou, Y.-C., Zhang, Y., Dahl, M.-L. and Bertilsson, L. (1992) Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects. Pharmacogenetics 2: 25–31.
Badger, T.M., Huang, J., Ronis, M. and Lumpkin, C.K. (1993) Induction of cytochrome P450 2E1 during chronic ethanol exposure occurs via transcription of the CYP2E1 gene when blood alcohol concentrations are high. Biochem. Biophys. Res. Commun. 190: 780–785.
Bertilsson, L., Aberg-Wistedt, A., Gustafsson, L.L. and Nordin, C. (1985) Extremely rapid hydroxylation of debrisoquine: a case report with implications for treatment with nortriptyline and other tricyclic antidepressants. Ther. Drug Monk. 7: 478–480.
Bertilsson, L., Lou, Y.Q., Du, Y.L., Liu, Y., Kuang, T.Y., Liao, X.M., Wang, K.Y., Reviriego, J., Iselius, L. and Sjöqvist F. (1992) Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquine and Smephenytoin. Clin. Pharmacol. Ther. 51: 388–397.
Bertilsson, L., Dahl, M-L., Sjöqvist, F., Aberg-Wistedt, A., Humble, M., Johansson, I., Lundqvist, E. and Ingelman-Sundberg, M. (1993) Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine. Lancet 341: 63.
Broly, F., Gaedigk, A., Heim, M., Eichelbaum, M., Morike, K. and Meyer, U.A. (1991) Debrisoquine/sparteine hydroxylation genotype and phenotype: Analysis of common mutations and alleles of CYP2D6 in European population. DNA Cell Biol. 10: 545–558.
Castillo, T., Koop, D.R., Kamimura, S., Triadafilopoulos, G. and Tsukamoto, H. (1992) Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride-and iron-dependent microsomal lipid peroxidation. Hepatology 16: 992–996.
Dahl-Puustinen, M.L., Lidén, A., Alm, C., Nordin, C. and Bertilsson, L. (1989) Disposition of perphenazine is related to polymorphic debrisoquine hydroxylation in human beings. Clin. Pharmacol. Ther. 46: 78–81.
Dahl, M.L., Johansson, I., Porsmyr-Palmertz, M., Ingelman-Sundberg, M. and Sjöqvist, F. (1992) Analysis of the CYP2D6 gene in relation to debrisoquine and desipramine hydroxylation in a Swedish population. Clin. Pharmacol. Ther. 52: 12–17.
Dahl, M.L. and Bertilsson (1993) Genetically variable metabolism of antidepressants and neuroleptic drugs in man. Pharmacogenetics 3: 61–70.
Dai, Y., Rashba-Step, J. and Cederbaum, A. (1993) Stable expression of human cytochrome P4502E1 in HepG2 cells: Characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 32: 6928–6937.
Ekström, G. and Ingelman-Sundberg, M. (1989) Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450. Biochem. Pharmacol. 38: 1313–1319.
Eliasson, E., Johansson, I. and Ingelman-Sundberg, M. (1990) Substrate, homone and cAMP-dependent regulation of cytochrome P450 degradation. Proc. Natl. Acad. Sci. USA 87: 3225–3229.
Eliasson, E., Mkrtchian, S. and Ingelman-Sundberg, M. (1992) Hormone-and substrate regulated intracellular degradation of cytochrome P450 (2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes. J. Biol. Chem. 267: 15765–15769.
Evans, W.E., Relling, M.V., Rahman, A., McLeod, H.L., Scott, E.P. and Lin, J.S. (1993) Genetic basis for low prevalence of deficient CYP2D6 oxidative drug metabolism in black Americans. J. Clin. Invest. 91: 2150–2154.
French, S.W., Wong, K., Jui, L., Albano, E., Hagbjörk, A.-L. and Ingelman-Sundberg, M. (1993) Effect of ethanol on cytochrome P450 (CYP2E1), lipid peroxidation and serum protein adduct formation in relation to liver pathology pathogenesis. Exp. Mol. Pathol. 58: 61–75.
Gaedigk, A., Blum, M., Gaedigk, R., Eichelbaum, M. and Meyer, U.A. (1991) Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am. J. Hum. Genet. 48: 943–950.
Gonzalez, F.J., Skoda, R.C., Kimura, S., Umeno, M., McBride, O.W., Gelboin, H.V., Hardwick, J.P. and Meyer, U.A. (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331: 442–446.
Hayashi, S.-I., Watanabe, J. and Kawajiri, K. (1991) Genetic polymorphism in the 5’-flanking region change the transcriptional regulation of the human cytochrome P450I1E1 gene. J. Biochem. 110: 559–565.
Heim, M.H. and Meyer, U.A. (1990) Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet 336: 529–532.
Ingelman-Sundberg, M., Johansson, I., Penttilä, K.E., Glaumann, H. and Lindros, K.O. (1988) Centrilobular expression of ethanol-inducible cytochrome P-450 (IIE1) in rat liver. Biochem. Biophys. Res. Commun. 157: 55–60.
Ingelman-Sundberg, M., Johansson, I., Persson, I., Lundqvist, E., Dahl. M.-L., Bertilsson, L. and Sjöqvist, F. (1992) Genetic polymorphisms of cytochromes P450: Interethnic differences and relationship to incidence of lung cancer. Pharmacogenetics 2: 264–271.
Ingelman-Sundberg, M., Johansson, I., Hu, Y., Terelius, Y., Eliasson, E., Clot, P. and Albano, E. (1993) Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation and possible role in the etiology of alcohol-induced liver disease. Alcohol,in press.
Johansson, I., Lindros, K.O., Eriksson, H. and Ingelman-Sundberg, M. (1990) Transcriptional control of CYP2E1 in the perivenous liver region and during starvation. Biochem. Biophys. Res. Commun. 173: 331–338.
Johansson, I., Yue, Q.Y., Dahl, M.L., Heim, M., Säwe, J., Bertilsson, L., Meyer, U.A., Sjöqvist, F. and Ingelman-Sundberg, M. (1991) Genetic analysis of the interethinic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine. Eur. J. Clin. Pharmacol. 40: 553–556.
Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M.L., Sjöqvist, F. and Ingelman-Sundberg, M. (1993a) Inherited amplification of an active gene in the cytochrome P4502D-locus as a cause of ultrarapid metabolism of debrisoquine. Proc. Natl. Acad. Sci. USA,in press.
Johansson, I., Oscarsson, M., Bertilsson, L., Yue, Q.Y., Dahl, M.-L., Sjöqvist, F. and Ingelman-Sundberg, M. (1993b) Genetic analysis of the Chinese CYP2D locus. Characterization of variant CYP2D6 genes present in subjects with diminished capability for debrisoquine hydroxylation. Manuscript.
Kalow, W. and Bertilsson, L. (1993) Interethnic factors affecting drug responses. In: Testa, B. and Meyer, U.A. (eds.): Advances in Drug Research,Academic Press Inc, London 1993, in press.
Masimirembwa, C.M., Johansson, I., Hasler, J.A. and Ingelman-Sundberg, M. (1993) Genetic polymorphism of cytochrome P450 2D6 in Zimbabwean population. Pharmacogenetics,in press.
McBride, O.W., Umeno, M., Gelboin, H.V. and Gonzalez, F.J. (1987) A Taq I polymorphism in the human P450IIE1 gene on chromosome 10 (CYP2E) Nucleic Acids Res. 15: 10071.
Morimoto, M., Hagbjörk, A.-L., Nanji, A.A., Ingelman-Sundberg, M., Lindros, K. O., Albano, E. and French, S.W. (1993) Role of CYP2E1 in alcoholic liver disease pathogenesis. Alcohol, in press.
Nelson, D.R., Kamataki, T., Waxman, D.J., Guengerich, F.P., Estabrook, R.W., Feyereisen, R., Gonzalez, F.J., Coon, M.J., Gunsalus, I.C., Gotoh, O., Okuda, K. and Nebert, D.W. (1993) The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA and Cell Biol. 12: 1–51.
Persson, I., Johansson, I., Bergling, H., Dahl, M.-L., Högberg, J., Rannug, A. and IngelmanSundberg, M. (1993) Genetic polymorphism of CYP2E1 in a Swedish population. Relationship to the occurrence of lung cancer. FEBS Leu. 319: 207–211.
Romkes, M., Faletto, M.B., Blaisdell, J.A., Rauchy, J.L. and Goldstein, J.A. (1991) Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 30: 3247–3255.
Ronis, M.J.J., Crough, J., Mercado, C., Irby, D., Valentine, C., Lumpkin, C.K., IngelmanSundberg, M. and Badger, T.M. (1993) Cytochrome P450 CYP2E1 induction during alcohol exposure occurs by a two step mechanism associated with blood alcohol concentrations in rats, J. Pharm. Exp. Ther. 264: 944–950.
Takahashi, H., Johansson, I., French, S.W. and Ingelman-Sundberg, M. (1992) Effects of dietary fat consumption on activities of the microsomal ethanol oxidizing system and ethanol-inducible cytochrome P450 in the liver of rats chronically fed ethanol. Pharmacol. Toxicol. 70: 347–352.
Terelius, Y., Norsten-Höög, C., Cronholm, T. and Ingelman-Sundberg, M. (1991) Acetaldehyde as an efficient substrate for ethanol-inducible cytochrome P450 (CYP2E1). Biochem. Biophys. Res. Commun. 179: 689–694.
Terelius, Y., Lindros, K. O., Albano, E. and Ingelman-Sundberg, M. (1992) Isozyme-specificity of cytochrome P450-mediated hepatotoxicity. In: Rein, H. and Ruckpaul, K. (eds.): Frontiers of Biotransformation, vol 8, Akademie Verlag, Berlin, pp. 187–232.
Tsukamoto, H., French, S.W., Benson, N., Delgado, G., Rao, G.A., Larkin, E.C. and Largman, C. (1985) Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology 5: 224–232.
Uematsu, F., Kikuchi, H., Ohmachi, T., Sagami, I., Motomiya, M., Kamataki, T., Komori, M. and Watanabe, M. (1991) Restriction fragment length polymorphism of the human cytochrome P450IIE1 gene. Nucleic Acids Res. 19: 2803.
Wang, S.L., Huang, J., Lai, M.D., Liu, B.H. and Lai, M.L. (1993) Molecular basis genetic variation in debrisoquine hydroxylation in Chinese subjects: Polymorphism in RFLP and DNA sequence of CYP2D6. Clin. Pharmacol. Ther. 53: 410–418.
Yue, Q.Y., Bertilsson, L., Dahl-Paustinen, M.L., Säwe, J., Sjöqvist, F., Johansson, I. and Ingelman-Sundberg, M. (1989) Dissociation between debrisoquine hydroxylation phenotype and genotype among Chinese. Lancet ii: 870.
Zhukov, A., Werlinder, V. and Ingelman-Sundberg, M. (1993) Purification and characterization of two membrane bound serine proteinases from rat liver microsomes active in degradation of cytochrome P450. Biochem. Biophys. Res. Commun.,in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Ingelman-Sundberg, M. et al. (1994). Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicity. In: Jansson, B., Jörnvall, H., Rydberg, U., Terenius, L., Vallee, B.L. (eds) Toward a Molecular Basis of Alcohol Use and Abuse. Experientia, vol 71. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7330-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7330-7_20
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7332-1
Online ISBN: 978-3-0348-7330-7
eBook Packages: Springer Book Archive